FFFC MONSTA MORTGAGE NEWZZZ // FastFunds Financial

New Post Public Reply Private Reply Replies (1) Message Board

Apr 4, 2013 at 9:32 AM

FFFC >> MONSTA MORTGAGE NEWZZZ // FastFunds Financial Corporation and Net Life Holdings See New Mortgage Product Requiring No Credit Verification Suited for the Large Demographic Group of Boomerang Buyers
Boomerang Buyers Estimated at Approximately 6 Million

Press Release: FastFunds Financial Corp. – 10 minutes ago
Email
RecommendTweet
Print
RELATED QUOTES
Symbol Price Change
FFFC 0.0055

WEST PALM BEACH, FL--(Marketwired - Apr 4, 2013) - FastFunds Financial Corporation (OTCQB: FFFC) and Net Life Holdings reported today that its new innovative mortgage product will target the large demographic group of boomerang buyers, estimated at more than 6 million. These are previous homeowners who have experienced foreclosures, short sales and deed in lieu of foreclosure circumstances in their past. These buyers are referred to as boomerang buyers; people who bounce back from losing their previous home to become homeowners again.
The various government agencies have waiting periods for buyers who previously lost their home due to a foreclosure or similar event:
The waiting period for a Federal Housing Administration (FHA) Loan is 3 years for Foreclosure, 3 years for Short Sale, and 3 years for a Deed in lieu of foreclosure.
The waiting period for a FHA Loan if there were extenuating circumstances is 1-2 years for Foreclosure, and 1-2 years for a Deed in lieu of foreclosure.
The waiting period for a Fannie Mae or Freddie Mac is 7 years for Foreclosure.
The waiting period for a Fannie Mae or Freddie Mac, less than 10% down is 7 years for Short Sale, and 7 years for a Deed in lieu of foreclosure.
The waiting period for a Fannie Mae or Freddie Mac, 10% down is 4 years for Short Sale, and 4 years for a Deed in lieu of foreclosure.
The waiting period for a Fannie Mae or Freddie Mac, 20% down is 2 years for Short Sale, and 2 years for a Deed in lieu of foreclosure.
It is also estimated that nearly 3.4 million households potentially could qualify for an FHA loan because it's been three years since the loss of their home, but many people still do not have the sufficient credit to get a loan.
The Company believes the NET LIFE LCMO® (Life Collateralized Mortgage Obligation) could substantially improve the boomerang buyer get back into a new home and help alleviate America's banking and mortgage crisis. A NET LIFE LCMO® is a residential, business or corporate real estate mortgage which is not based on credit history; only on the collateral. All that is required for which to qualify is: (a.) that you are healthy, (b.) that the property maintains and sustains its stated value and (c.) that you have the income to pay your mortgage.
About FastFunds Financial Corporation
FastFunds Financial Corporation is a holding company that is publicly traded on the Over-the-Counter QB under the symbol "FFFC." The Company currently operates in the financial services industry segment with a single credit card services portfolio. The Company is currently seeking new business opportunities to diversify and complement our current services and products, enhance our technical capabilities or otherwise offer growth opportunities for our stockholders.
About NET LIFE
NET LIFE Financial Processing, Inc., a wholly owned subsidiary of FFFC, is a development stage company formed in 2013 and recently acquired the assets related to the processing and servicing of loans generated from NET LIFE Financial Holdings Trust (www.netlifefinancial.com). NET LIFE Holdings has developed unique financial products principally for the mortgage industry.
FORWARD-LOOKING STATEMENTS
This news release may include "forward-looking statements" regarding FastFunds Financial Corporation, and its subsidiaries, business and project plans. Such forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where FastFunds Financial Corporation expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. FastFunds Financial Corporation does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Contact:
For Further Information
Net Life Holdings
support@netlifefinancial.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...